Clicky

Selective Serotonin Reuptake Inhibitors, Phenylpiperazine, Tetracyclic, Tricyclic, Atypical, CNS Stimulant, MAO Inhibitors, Serotonin-Norepinephrine

DUBLIN, March 8, 2021 /PRNewswire/ — The “US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026” report has been added to ResearchAndMarkets.com’s offering. The complete research report is divided into several sections focusing on the approaches followed for sales and marketing, research and development, specific clinical trials and tailored capabilities of the major bio-pharmaceutical companies […]

Selective Serotonin Reuptake Inhibitors, Phenylpiperazine, Tetracyclic, Tricyclic, Atypical, CNS Stimulant, MAO Inhibitors, Serotonin-Norepinephrine Read More »

PAOG Announces RELAX-RX Nutraceutical For $18 Billion Anxiety And Depression Treatment Market

Sandusky, Ohio–(Newsfile Corp. – March 8, 2021) – PAO Group, Inc. (OTC Pink: PAOG) today announced initiating the development of its new nutraceutical, RELAX-RX, targeting the anxiety and depression treatment market anticipated to reach a value of $18 billion by 2025. The company recently announced plans to produce a variety of nutraceuticals for additional applications

PAOG Announces RELAX-RX Nutraceutical For $18 Billion Anxiety And Depression Treatment Market Read More »

Selective Serotonin Reuptake Inhibitors, Phenylpiperazine, Tetracyclic, Tricyclic, Atypical, CNS Stimulant, MAO Inhibitors, Serotonin-Norepinephrine

DUBLIN, March 8, 2021 /PRNewswire/ — The “US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026” report has been added to ResearchAndMarkets.com’s offering. Research and Markets Logo The complete research report is divided into several sections focusing on the approaches followed for sales and marketing, research and development, specific clinical trials and tailored capabilities of

Selective Serotonin Reuptake Inhibitors, Phenylpiperazine, Tetracyclic, Tricyclic, Atypical, CNS Stimulant, MAO Inhibitors, Serotonin-Norepinephrine Read More »

Diagnostic Performance of the 4‐item Geriatric Depression Scale for Depression Screening in Older Patients with Cancer: The ELCAPA Cohort Study – Lafont – – The Oncologist

Background In older patients with cancer, depression is difficult to assess because of its heterogeneous clinical expression. The 4‐item version of the Geriatric Depression Scale (GDS‐4) is quick and easy to administer but has not been validated in this population. The present study was designed to test the diagnostic performance of the GDS‐4 in a

Diagnostic Performance of the 4‐item Geriatric Depression Scale for Depression Screening in Older Patients with Cancer: The ELCAPA Cohort Study – Lafont – – The Oncologist Read More »

‘Sunshine Calls:’ Study shows a simple phone call can help reduce depression, anxiety

AUSTIN (KXAN) — In a time when social distancing can save lives, it has also forced our most vulnerable population to become more isolated, but a phone call can help brighten a day. “Even before the pandemic social isolation was a real concern for us,” said Seanna Marceaux with Meals on Wheels Central Texas. “What

‘Sunshine Calls:’ Study shows a simple phone call can help reduce depression, anxiety Read More »